Sign in

Amit Banati

Chief Financial Officer at Kenvue
Executive

About Amit Banati

Amit Banati, age 56, was appointed Chief Financial Officer of Kenvue effective May 12, 2025, after a 30-year career in consumer products finance and operations at Kellanova/Kellogg, Kraft Foods, Cadbury Schweppes, and Procter & Gamble; he also serves on the board of Fortune Brands Innovations . He steps in as Kenvue focuses on profitable growth, margin improvement, cash flow, and forecasting agility; management framed his mandate alongside Q1’25 results, highlighting his transformation experience and priorities in data-driven resource allocation and integrated planning . For context, Kenvue delivered 2024 net sales of $15.5B (+0.1% y/y), gross profit margin of 58.0% (adjusted 60.4%), operating income margin 11.9% (adjusted 21.5%), net income $1.0B (adjusted $2.2B), diluted EPS $0.54 (adjusted $1.14), and free cash flow of $1.3B .

Past Roles

OrganizationRoleYearsStrategic impact
Kellanova (formerly Kellogg Company)Vice Chairman & CFODec 2022–May 2025Led finance during transformation; prior APAC/AMEA leadership; public-company CFO since 2019 .
Kellogg CompanySVP & CFOJul 2019–Dec 2022Enterprise-wide finance leadership across global snacking/cereal; transformation execution .
Kellogg CompanyPresident, Asia Pacific; later APMEAMar 2012–Jul 2018; Jul 2018–2019Oversaw growth and operations across Asia Pacific, Middle East & Africa .
Kraft Foods; Cadbury Schweppes; Procter & GambleVarious finance, general management, and board rolesNot disclosedGlobal finance and operating leadership across multiple consumer categories .

External Roles

OrganizationRoleYears
Fortune Brands InnovationsDirectorNot disclosed

Fixed Compensation

ComponentDetail
Base salary$900,000 .
Target annual bonus110% of base salary .
Target annual equity grant$3.2 million aggregate target value; same vehicles/vesting as other executive officers .
Sign-on cash$2,500,000 paid shortly after start; subject to 100% repayment if employment ends before 1st anniversary, 50% before 2nd anniversary (exceptions for death/disability, good reason, or termination without significant misconduct) .
Sign-on equityRSUs with $4,000,000 fair value, granted within two months of start; standard 3-year vesting; continued vesting or full vest on death/disability per offer letter .
Transaction-conditioned awards$4,000,000 cash upon close of Mars–Kellanova merger by Aug 13, 2026, and RSUs with $2,500,000 fair value within two months thereafter; equity vests over 3 years; eligibility/repayment terms per offer letter .
Severance plan eligibilityEligible Employee under Executive Severance Pay Plan of Kenvue Inc. and U.S. affiliates .
Restrictive covenantsStandard agreement includes non-competition, non-solicitation, and confidentiality .

Performance Compensation

Kenvue uses a balanced, pay-for-performance design for executives (including the CFO):

  • Annual bonus structure: 70% company “Kenvue Performance Factor” based on financials and 30% Individual Compensation Factor .
  • Company financial measures (annual plan): Organic net sales, Adjusted gross profit margin, Adjusted net income, and Free cash flow; metrics are non-GAAP for plan purposes -.
Annual incentive metrics (company component)WeightingTarget/Actual/PayoutVesting/Timing
Organic net sales (non-GAAP plan basis)Part of 70% company factor Not individualized; company framework disclosed Cash, paid post-year-end .
Adjusted gross profit margin (non-GAAP plan basis)Part of 70% company factor Not individualized; company framework disclosed Cash, paid post-year-end .
Adjusted net income (non-GAAP plan basis)Part of 70% company factor Not individualized; company framework disclosed Cash, paid post-year-end .
Free cash flow (non-GAAP plan basis)Part of 70% company factor Not individualized; company framework disclosed Cash, paid post-year-end .

Long-term incentives (standard executive design; applies to his 2025 annual grant, which will use same vehicles/vesting):

LTI vehicleMixPerformance metric(s)Measurement windowVesting
PSUs50% of grant Organic net sales CAGR; Adjusted diluted EPS CAGR, with Relative TSR modifier (0.75/1.0/1.25) vs Performance Peer Group 3 years Cliff vest after 3 years (subject to performance/continued service) .
Stock options30% of grant Share price appreciationN/A1/3 each on 1st, 2nd, 3rd anniversaries .
RSUs20% of grant Time-basedN/A1/3 each on 1st, 2nd, 3rd anniversaries .

Sign-on equity vesting:

AwardGrant timingFair valueVesting
Sign-on RSUsWithin two months of May 12, 2025 $4,000,000 Over three years; full vest on death/disability; continued vest on qualifying separation; repayment terms for cash sign-ons per offer .
Transaction-conditioned RSUsWithin two months after Mars–Kellanova close by Aug 13, 2026 $2,500,000 Over three years; treatment on qualifying separation per offer .

Equity Ownership & Alignment

ItemDetail
Initial beneficial ownership113 common shares, held indirectly via trust (Form 3/A filed May 27, 2025) .
Ownership as % of outstandingNot disclosed (no calculation provided) .
Vested vs. unvestedSign-on RSUs unvested at grant, vest ratably over 3 years; 2025 annual LTI will follow standard PSU/option/RSU schedules .
Pledging/hedgingProhibited for executive officers under Kenvue’s Stock Trading Policy .
Executive ownership guidelinesCEO 6x salary; other executive officers (incl. CFO) 3x salary; until met, must hold 75% of after-tax shares from vesting .
ClawbacksTwo recoupment policies: NYSE-aligned financial restatement clawback and broader misconduct recoupment covering annual and long-term incentives .

Employment Terms

TermDetail
Start date and roleCFO; effective May 12, 2025 .
Offer letter key economics$900k salary; 110% target bonus; $3.2M annual LTI target; $2.5M sign-on cash; $4.0M sign-on RSUs; $4.0M cash + $2.5M RSUs upon Mars–Kellanova close by Aug 13, 2026 .
Vesting/repayment protectionCash sign-ons: 100% repay if depart before 1st anniversary; 50% before 2nd; equity sign-ons vest over 3 years; death/disability => equity vests in full; good reason/termination without significant misconduct => continued vesting; transaction-conditioned sign-ons still paid if condition satisfied post-termination in qualifying cases .
SeveranceEligible under Executive Severance Pay Plan (details administered per plan) .
Restrictive covenantsNon-compete, non-solicit, confidentiality in standard agreement .
Related partiesNo Item 404(a) related-party transactions and no family relationships disclosed .
Governance signalsAnti-hedging/pledging, equity grant timing controls, and clawbacks in force .

Performance & Track Record

  • Background and focus: Brings CFO and operating leadership across multiple continents and categories; mandate emphasizes revenue growth via data-driven resource allocation, margin/cost profile improvement, cash flow strengthening, and more agile planning/forecasting .
  • Certification: Signed SOX 302 CFO certification for Kenvue’s Q3 2025 10-Q, indicating ownership of controls and disclosures for that period .
  • Say-on-pay context: Kenvue’s 2024 say-on-pay received ~97% support, reflecting investor alignment with program design he now participates in .

Compensation Structure Notes (Program Design and Peer Benchmarking)

  • Annual incentives: 70% company factor (organic net sales, adjusted gross margin, adjusted net income, free cash flow), 30% individual factor; non-GAAP adjustments used for plan purposes -.
  • Long-term incentives: 50% PSUs (organic net sales CAGR, adjusted diluted EPS CAGR; Relative TSR modifier vs a 30-company performance peer group), 30% options, 20% RSUs .
  • Benchmarking: Compensation decisions reference a 17-company Compensation Peer Group and a broader 30-company Performance Peer Group (adds names like Haleon, Reckitt, Unilever, PepsiCo, P&G, etc.) -.

Investment Implications

  • Retention risk: Low near-term given substantial sign-on cash ($2.5M) and multi-year equity ($4.0M + potential $2.5M) with repayment and continued-vesting protections that incentivize staying through at least two years and beyond; transaction-conditioned awards (up to $6.5M combined) further anchor retention through mid-2026 depending on closing timing .
  • Selling pressure: Time-based RSUs vest over three years (including sign-on and potential transaction-conditioned equity), creating predictable annual supply; anti-hedging/pledging and ownership guidelines (3x salary for CFO) mitigate misalignment and encourage net share retention (75% of after-tax until compliant) .
  • Pay-for-performance alignment: Annual bonus ties to organic growth, margins, profitability, and free cash flow; PSUs center on multi-year organic sales and EPS CAGRs with a Relative TSR modifier—directly linking compensation to durable growth and market-relative outcomes .
  • Governance quality: Dual clawbacks, trading restrictions, and equity grant guardrails indicate strong compensation risk controls; 2024 say-on-pay ~97% support suggests investor comfort with design he will be subject to .
  • Track record portability: Experience leading finance and operations across APAC/AMEA and global snacking/cereal should support Kenvue’s agenda in brand investment, productivity, and forecasting rigor articulated at appointment .

Overall, the package emphasizes retention and near-term continuity while leveraging Kenvue’s established incentive architecture to drive multi-year growth, margin expansion, and cash generation—key levers for equity value in consumer health .